B2B Appointment Setting for Healthcare: Access, Not Persuasion

Most healthcare vendors don't lose these deals on the merits. They lose them earlier, at the point where nobody with authority ever sees the message at all. The chief nursing officer is on a unit. The VP of clinical operations has rounds back to back until four. The health system CIO keeps an inbox that files anything unfamiliar into a folder no one opens, plus a phone number that rings an assistant who has been asked, politely but firmly, to guard the day. I'm Raphael Presberg, Founder and CEO of Moriah, a LinkedIn marketing agency and a LinkedIn Certified Marketing Partner. B2B appointment setting for healthcare is an access problem long before it is a persuasion problem, and those two jobs look nothing alike.

One clarification first. This page is about B2B healthcare: medical devices, diagnostics, clinical software, health IT, revenue cycle and clinical services sold to hospitals, health systems, clinic groups and payers. Clinicians marketing to patients follows a different rulebook entirely, and it isn't work we take.

Three Doors, and Two of Them Are Shut

Trace how a message actually reaches a healthcare executive and the picture turns uncomfortable fast.

Door one is email. Health systems run some of the most aggressively filtered mail environments of any industry, for reasons that are hard to argue with, and the general address published on a directory page gets triaged by someone paid to keep it clear. Cold email here sits at the low end of an already low benchmark: roughly 1 to 3 percent replies across B2B generally, and a clinical or administrative inbox is not where that average improves.

Door two is the phone. Worth saying plainly, a hospital switchboard is not a sales channel. The direct line, where one exists, gets answered by an assistant. The mobile is personal and was never given to you.

Door three is the conference. Healthcare has excellent ones, and a booth at the right show puts you in the same building as the people you want. It also squeezes a year of relationship building into three days and hands you no control over who wanders up.

What stays open is the door where the buyer sets the terms. A director of perioperative services can read a message at nine at night, decide in fifteen seconds whether the sender is worth a reply, and answer or not answer without anyone else in the organization being involved. Which is why well-run LinkedIn outreach tends to sit closer to 10 to 15 percent replies than 1 to 3 percent. Not because the message is cleverer. Because the recipient can see who sent it, on their own time, and reply without going through a gatekeeper.

What Earns a Reply From Someone Who Has No Time

The reply rate on a message to a busy clinical or operational leader gets decided before the first word, by choices most vendors get wrong.

Length is the first one. Someone reading between cases will read three sentences and will not read eight. Anything that requires scrolling is answered with silence.

The second is whether the message names a problem in the language the recipient's own department uses. A director of pharmacy does not have a "workflow optimization challenge." They have a med rec backlog, or a 340B compliance headache, or a technician vacancy that has been open since March. Write the abstract version and you've announced that you don't really know this world. Name the specific operational reality and you've passed, in one line, the only test that matters at this stage.

Third is the ask. "Do you have 30 minutes to learn about our platform" asks a person with no unclaimed 30 minutes to spend them on your education. Far better is a question that can be answered in a single line, from a phone, in a corridor: are they the one who owns this decision, do they recognize the problem you named, would a short conversation in the next few weeks be useful at all. The first message is trying to get a reply. The meeting is what the third message is for.

Fourth is who the message comes from. A note from a named executive at your company, whose profile shows a year of reasoning about this exact category, is not the same note as one from a nameless account, even when the words are identical. This is where targeted outreach stops being separable from personal branding, and it's the whole reason we don't sell them apart.

Scheduling Around Clinical Reality

Getting the yes is only half of it. Healthcare is one of the few sectors where the meeting itself has to be engineered, because the calendar you're booking into doesn't behave like a normal business calendar.

A clinical leader's week is built in blocks, and the blocks don't negotiate. Rounds, clinic sessions, OR schedules, on-call rotations, shift handovers. What's left is early morning, the end of the day, and administrative time that varies by role and by institution. An operational or IT leader has a different constraint with much the same effect: change freezes, go-live weekends, cutover periods, and a fiscal year end that for a great many health systems lands nowhere near December.

So we book differently.

• Short by default. Twenty or twenty five minutes, stated in the invitation, with a clear reason the conversation can be that short.
• Offered as specific slots, not an open link. A calendar link asks the busiest person in the building to do the scheduling work. Two concrete times, with a third if neither lands, asks them to type one word.
• Copied to whoever protects the diary. In this sector the assistant isn't an obstacle to be routed around. Once a leader has said yes, the assistant is the person who makes it real, and treating them accordingly is the difference between a booked meeting and a booked meeting that happens.
• Reconfirmed close to the date. A clinical emergency outranks you, always. A meeting that quietly evaporates because nobody reconfirmed wasn't a lost meeting, it was an unfinished one, and rescheduling it is part of the job rather than an admission of failure.

What Has to Be True Before the Meeting

A booked slot isn't the deliverable. A meeting that survives first contact is. Three conditions decide that, and all three are set before the invitation goes out.

The right person has to be in the room, or at least the right one of several. Healthcare purchases pull in clinical, technical, financial and supply chain functions, and a meeting with someone who can't start a process is a pleasant conversation that ends in a forward that never happens. We qualify for the ability to convene, not just for interest.

The agenda has to be something the attendee can act on. Not a capability overview. A specific operational question with a decision behind it: whether the problem you named is worth scoping, who else would need to see it, what evidence their institution would want before a pilot.

And your name has to arrive before your message does. When a director looks you up between the reply and the meeting, and the search returns a company page posting booth numbers alongside executives whose profiles are three roles out of date, the meeting is already weaker than it was. When it returns your clinical or technical leadership publishing sober, useful material about the same problem, the meeting starts somewhere else entirely. In a sector where buyers check who they're dealing with, expect that lookup on any serious opportunity whether or not you've prepared for it.

How Moriah Runs B2B Appointment Setting for Healthcare

We start with a deep discovery of your business and the single business objective you want LinkedIn to serve. For a company coming to us for healthcare appointment setting, that objective is usually qualified first meetings with people who can genuinely start a process.

From there we build the target map: the institutions, the roles, and inside each role the specific operational reality that makes your offer relevant now rather than eventually. Targeted outreach then runs at a cadence of around 200 messages per week, written for individual recipients rather than blasted at a list, while personal branding publishes under your executives' own names so the lookup after a reply finds substance. LinkedIn Ads run when they serve the objective, keeping your leaders in front of the accounts targeted outreach has already touched.

Everything is executed in-house by our team: strategy, content production, targeted outreach and campaign management. Moriah is a done-for-you managed service. No training, no courses, no workshops, and we don't hand you a playbook to run yourself.

On claims, we work inside the boundary your sector requires. We write no efficacy or clinical outcome claims, we publish no patient outcomes and no comparative clinical language, and where your company has medical, legal or regulatory review, content is produced with enough lead time for your reviewers and built to their requirements rather than ours.

Who This Is For

• Medical device, diagnostics, clinical software, health IT, revenue cycle and clinical services companies selling into hospitals, health systems, clinic groups or payers.
• Commercial leaders whose pipeline problem sits upstream: too few first meetings with people who can act, rather than weak conversion once a meeting happens.
• Companies whose current outbound is a cold list plus a sequence tool, producing plenty of volume and almost no replies.
• Teams whose meetings come almost entirely from two or three trade shows a year, with long quiet stretches in between.
• Leadership teams willing to publish from personal profiles, since that's what makes the targeted outreach land.
• Companies that would rather hand one accountable team the whole engine than coordinate a list vendor, a ghostwriter and a separate ads agency.

We work with B2B companies only. If your objective is patient acquisition, we're not the right firm, and if your buyers genuinely aren't active on LinkedIn, we'll say so rather than take the engagement.

How the Engagement Runs

1. Discovery. Your business, your buyers, and the one objective LinkedIn is being asked to serve.
2. Target map. The institutions and roles worth reaching, and the operational trigger that makes each one relevant now.
3. Message and profile work. Outreach written per segment, and your executives' profiles and publishing positions prepared, so the lookup after a reply supports you instead of undermining you.
4. Launch in parallel. Targeted outreach at roughly 200 messages a week, personal branding at one to three posts a week, ads where they earn their place. All three point at the same objective.
5. Book, confirm, hold. Slots proposed, assistants included, meetings reconfirmed, and no-shows rescheduled rather than written off.
6. Measure and adjust. Reply rates by role and institution type, meetings held, and what the conversations tell us about which operational problem to lead with next.

What to Expect

The reply rate usually moves first. The tone of the replies moves second. Messages that name a real operational problem, sent by someone the recipient can place, get answered by people who have never answered a vendor before. Some of those answers are a clean no, which is worth having early.

Then meetings start holding, and the reconfirmation habit does more for that than any change in messaging.

The slower change is the one that compounds. As your executives become recognisable in the category, targeted outreach stops being an introduction and becomes a follow-up to something the recipient has already read. That's when reply rates settle at the top of the range rather than the bottom.

We don't guarantee a number of meetings, and I'd be wary of any agency in this sector that does, given how long clinical evaluation and capital cycles run. What we commit to is running the full engine, measuring honestly, and proving the value with real business cases and with the data an engagement produces.

Why the Three Pillars Run Together

Appointment setting is one focus area out of three, and it isn't something you can buy from us on its own. Personal branding, targeted outreach and LinkedIn Ads always run together as one business engine, because that's how LinkedIn actually performs.

The failure patterns are consistent enough that I can predict them. A company that publishes steadily and activates nothing around it gets an engagement chart and no pipeline. A company that sends targeted outreach with nothing published behind it is a stranger asking a busy clinician for time, and in a sector that checks everyone, being a stranger is disqualifying. Personal branding builds the credibility, targeted outreach converts it into conversations, ads extend the reach. The mix adapts to your objective: when your buyers aren't publishing much themselves yet, we lean harder on targeted outreach and use content to make the sender credible rather than to build an audience.

There's a reason to publish from people rather than from the company account, too. Content published from a personal profile performs roughly 5 to 10 times better than the same content from a company page, and in a sector where the reader is assessing judgment, a corporate account has none to show.

For years LinkedIn was treated as a recruitment platform, or a static company page for the occasional announcement. Fair enough at the time. It isn't the whole picture anymore, and in healthcare, where the people you need are unreachable by almost every other route, that gap is expensive.

Pricing and Commitment

Moriah is a monthly retainer covering all three pillars run together and executed in-house: $4,000 per month in the United States, £3,000 per month in the United Kingdom, and €3,000 per month in France. No per-post or per-tool pricing.

There is no commitment: no minimum term, no lock-in, cancel anytime. The engagement runs long enough to gather real data and demonstrate results, but you're never tied in. Most clients stay well past the beginning because the engine works, not because a contract obliges them to.

Frequently Asked Questions

What is B2B appointment setting for healthcare? It's the work of getting qualified first meetings with the clinical, operational, financial and IT leaders who decide inside hospitals, health systems, clinic groups and payers. In this sector it's primarily an access problem. The people you need have filtered inboxes, protected phone lines and days built around clinical blocks, so the job is reaching them at all and then booking into a calendar that doesn't behave like a normal business calendar.

Why does LinkedIn outreach work better than cold email here? Because the recipient controls the encounter. They can look at a message when they choose, see exactly who sent it, and reply without anyone else being involved. Cold email typically returns about 1 to 3 percent replies, and a clinical or administrative inbox is a harsh environment even by that standard. Well-run LinkedIn outreach tends to sit nearer 10 to 15 percent.

Do you contact clinicians directly? We reach decision-makers in a professional context on LinkedIn, where they can respond on their own terms. Nobody gets interrupted mid-shift. We build the target list from the roles and institutions your offer is actually relevant to rather than working off a generic bought list, and we qualify for the ability to start a process rather than messaging every plausible title at an institution.

How do you handle our medical, legal and regulatory review? Content is produced in batches with enough lead time for your reviewers and built to their requirements rather than ours. No efficacy claims, no patient outcomes, no comparative clinical language. Anything awaiting review simply waits while the other pillars keep running. We never route around your internal process.

Can we buy appointment setting on its own? No. It's one focus area out of three, and personal branding, targeted outreach and LinkedIn Ads always run together as one business engine. That's the concept, not a packaging decision. Outreach sent with no content behind it produces no business, and content published with nothing activated around it produces no business either.

How many meetings will we get? We don't sell a meeting quota, because a number promised in advance gets met by lowering the bar on who counts as qualified. We commit to running the full engine at a real cadence, measuring reply rates and held meetings honestly, and showing you what the data says. Healthcare cycles are long, and an agency promising a fixed monthly count in this sector is telling you something about its qualification standard.

Who at our company needs to be involved? Someone senior enough to be the named sender and to publish under their own name, usually a commercial lead plus a clinical or technical executive, and whoever owns the sales calendar. We need subject-matter input from them and a willingness to publish from a personal profile. That second point is a genuine qualification question, and if a leadership team can't get there, this isn't the right service for them.

What happens when a decision-maker cancels? We reconfirm before the date and reschedule rather than treat a cancellation as a lost meeting. In healthcare a clinical emergency outranks any vendor conversation, and building that into the process is part of the job. We also copy the assistant who owns the diary, since that's usually who makes a rescheduled meeting actually happen.

How much does it cost? A monthly retainer covering all three pillars run together and executed in-house: $4,000 per month in the United States, £3,000 per month in the United Kingdom, €3,000 per month in France. No per-post or per-tool pricing.

Is there a minimum contract? No. No minimum term, no lock-in, cancel anytime.

How long before we see meetings? Replies come first, usually within the first weeks of a real cadence. Meetings follow as targeting sharpens and your executives become names the recipient recognizes. Contracts take as long as clinical evaluation, security review and capital cycles take, which in this sector is considerably longer than the meeting itself suggests.

Does the same engine serve objectives other than meetings? Yes. The same three pillars, weighted differently, serve thought leadership in your category, new partnerships, entering a new market, launching a new offer, visibility to institutional investors and recruiting. Any business objective has an answer with the right LinkedIn strategy, and we build the mix around the objective you name.

Get Started

If your healthcare pipeline is thin because you can't get in front of the people who decide, rather than because your product loses once you do, that's a solvable problem and a different one from the one most agencies address. Book a call and we'll map the roles worth reaching inside your target institutions, show you what the first message to each would say, and lay out what targeted outreach looks like with personal branding and LinkedIn Ads running alongside it. No commitment, and you'll get an honest answer about whether your buyers are active enough on LinkedIn to make it worth doing.